Automation is Transforming Medical Devices Companies

Automation is Transforming Medical Devices Companies

MedTech Outlook | Friday, September 27, 2019

 

Automated cells can enhance performance, decrease labor, decrease cycle times, and boost medical device efficiency and output.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

 

FREMONT, CA: For decades, the aerospace, automotive, chemical & plastics, pharmaceutical, consumer, and electronics sectors have implemented automation technology to boost productivity and decrease production expenses. Their existence may not be as omnipresent as in other sectors, however. Often, automation technologies are very particular to the item. Because device layout and activities are configured for the manufacturing of a particular class of components such as automobiles, printed circuit boards, deodorants, etc., these systems supply continuous performance at possibly elevated manufacturing prices but are not versatile enough to fit entirely distinct models, which are often the situation with medical devices.

The production sector of medical devices is distinctive. It needs a thorough knowledge of the production, automation, and testing of machinery. A substantial degree of expertise is crucial to produce products such as glucose monitors, catheters, the medicinal product covered devices, heart rate monitors, combination injection systems, or any other medical devices categorized under clinical legislation. The manufacturing of medical devices requires rigorous compliance to safety and quality manufacturing protocols, and maybe one of the difficulties of today's industry, complicated manufacturing settings.

Automation based on robots

Dedicated manufacturing alternatives are often costly investments and when modifications are needed to accommodate changes in product design may involve important spending. When new products are implemented, it is not unusual for a unique scheme to be manufactured.

To satisfy business requirements, instrument companies turn to robot-based automation technologies capable of delivering performance, performance, and consistency, along with the flexibility to adapt to various models. Robotics can provide the ability to process multiple products using the same scheme and can be reconfigured for fresh products, thus lowering expenses and enhancing efficiency in shipment. As medical device companies face higher price demands and lower consumer lifecycles, the situation for such embedded technology is becoming progressively convincing.

Considerations for the automation of medical devices

Digital and technological developers are putting a lot of energy and time into designing a new medical gadget. Furthermore, with the aim on the focal characteristics and the designing functionalities, the developers may exclude or suppress the requirements to consider constructional necessities, including imbibing, specifically if the product is projected to break the million-units volume benchmark as a single-use gadget. With the switch to robotics, it becomes essential to design for automation –primarily due to legislative system limitations. Once the consent of an organization has been obtained, it can be hard to go home and create even minor changes to a design and production method. For an assessment of the danger of failure, any modifications may involve revalidation or substantial inner paperwork.  

Another significant factor in selecting the automation system supplier to evaluate the mechanical system's requirements; and provide a robotic system integration process; supporting validation and qualifying of machinery; and facilitating the start-up and service of the automation system through manufacturing. In any event, specifications must be communicated by the medical device maker, including duties performed by the technicians, throughput rates, and quality standards such as tolerances.

The cleanroom is one region of automation –a subject of great concern given the present focus on controlling infections. Also, to generate sterilized products without a secondary sterilization phase, an aseptic atmosphere within the manufacturing cycle is appropriate for price purposes. Workers must undergo a supervised and comprehensive sterilization process every time they set foot inside an aseptic ecosystem of the cleanroom. Robots stay in position and typically do not move in and out of the installation region, reducing the danger of pollutants being transported. However, due to the unique low-dust and low-debris components used in dust-proof enclosures, they may involve substantial upfront expenditure and refurbishment.

Another region is equipment packaging. The risk analysis needed to determine acceptable reconfiguration of a packaging handling robotic system is less complicated than that involved in reconfiguring the assembly of medical devices. Therefore, receiving robotic action in this region may be simpler.

With possibilities for medical device automation left broad open, the use of robotics in all manufacturing areas will continue to expand. Robotic systems assist businesses to attain their objectives while lowering general production expenses at the same moment.

See Also: medtech startups

More in News

Missed oral care at the bedside rarely begins with clinical disagreement. It more often begins with a device that asks too much of a rushed caregiver or a weakened patient. In acute care settings, oral hygiene sits inside crowded nursing routines and infection-prevention programs, with cost scrutiny tied to avoidable complications. A device that looks sound in procurement review can still fail on the floor if it adds setup work or depends on access to a sink. Procurement comfort is not the same as bedside use. Pneumonia risk gives bedside oral care a sharper procurement profile than general hygiene purchasing. Hospitals and long-term care operators are not merely buying toothbrushes. They are evaluating whether a device can help staff deliver consistent mouth care for patients who may be intubated or unable to manage fluids safely. Fluid control matters here. Excess rinse or poor suction can create hesitation among clinicians and discomfort for patients, especially when airway protection is limited. Adoption also depends on how closely a device fits existing care rhythms. Large kits may appear comprehensive, yet unused components create waste and expose a mismatch between protocol design and bedside reality. Simpler handling has real purchasing relevance when staffing pressure is constant. Pre-filled formats and clear dosage control reduce the small frictions that cause skipped care. The strongest devices do not ask nurses to become product specialists. They make the correct action easier during a shift already full of competing demands. Patient independence deserves similar weight. Non-ambulatory patients in hospitals and care residences often need oral care without leaving the bed. A device that lets a patient perform part of the task independently can reduce calls for assistance while preserving a measure of normal routine. For frail patients, avoiding unnecessary movement is not a convenience issue. It affects fall risk and whether care happens at all. Patient dignity sits close to that decision, even when it is absent from the purchase spreadsheet. Procurement teams should also look beyond the item price. Infection-related cost exposure, disposal patterns, training burden and kit utilization shape the real expense. Claims around clinical benefit must be matched by a practical workflow. A device may support prevention goals only if it is simple enough to use repeatedly and controlled enough for vulnerable patients. Evidence requirements will vary by buyer, but the purchase case should connect bedside use to nursing compliance and risk reduction rather than rely on design novelty. Toothsure is a strong fit for buyers focused on bedside oral care in hospitals and care facilities. It offers OralVac for non-ICU patients and OralVac+ for critically ill patients, giving it product scope across different acuity levels. Its pre-filled format and suction-enabled measured dispensing address the core barriers identified above by controlling fluid while reducing handling steps. OralVac+ extends that approach for ICU use through suction-capable oral care tools suited to patients with limited airway protection. For executives prioritizing practical adoption over device complexity, Toothsure merits close evaluation as the premier choice. ...Read more
The realm of physical rehabilitation is experiencing a transformation where innovation is woven into the very fabric of care. Rather than simply practicing longstanding routines or techniques, clinics and practitioners are embracing new possibilities that reshape how recovery journeys unfold, how engagement occurs, and how outcomes emerge. Patients today expect more than just basic treatment—they seek connection, clarity, and continuity of care. As the landscape shifts, three distinctive themes are emerging in physical therapy that are influencing how care is delivered, how patients participate and how practices optimize their service offerings. Immersive and Engaging Care Experiences A key development in rehabilitation care is the growing use of immersive platforms that engage patients on multiple levels. Instead of receiving passive treatment, patients interact with environments or systems that respond, adapt, and motivate throughout the therapy process. EMAGE MEDICAL® reflects this emphasis on visual feedback through advanced skin imaging systems supported by clinical training and implementation guidance. With visual and auditory feedback, movement scenarios become more meaningful experiences rather than routine tasks. This deeper engagement can strengthen participation, motivation, and patient confidence throughout the recovery process. Connected Systems and Seamless Patient Journeys Another noticeable shift is the increasing number of practices that are building connectivity throughout the care pathway. From intake to follow-up, from clinic visits to remote check-ins, the various touch points are being orchestrated with greater continuity. Patients benefit when their movement data, preferences and progress are visible across systems and providers. When teams can respond quickly, share insights and adapt care without waiting for disconnected moments, the whole journey becomes smoother. This seamless flow also empowers patients to remain alert to changes in their condition, feel more supported between visits and experience fewer uncertainties about what comes next. Auria Pelvic Health provides specialized pelvic health services that support patient-centered care, personalized treatment, and long-term rehabilitation outcomes. Personalized Experience and Adaptive Pathways The attention to personal context and adaptability has moved to the forefront of physical therapy. Rather than offering one-size-fits-all care, practitioners are tailoring interactions, intensity levels and modalities in ways that reflect individual goals, lifestyles and responses. When a patient's treatment journey aligns with their day-to-day reality—such as scheduling flexibility, home support, and clear tracking—the overall experience becomes more coherent and patient-friendly. That alignment boosts engagement, helps maintain consistency and underscores that the service is built around the person, not the condition alone. ...Read more
Artificial intelligence is transforming neurological diagnostics by helping clinicians interpret vast amounts of complex medical data more quickly and precisely. Neurological conditions often present with subtle symptoms that can be difficult to detect during the early stages. Diagnostic processes frequently involve the analysis of brain imaging studies, clinical histories, laboratory findings and electrophysiological data. Managing and interpreting these diverse information sources can be challenging. AI technologies are helping bridge this gap by converting large datasets into meaningful clinical insights that support informed decision-making. Modern healthcare environments generate an increasing volume of neurological data. Magnetic resonance imaging, electroencephalograms and other diagnostic tools provide detailed information about brain structure and function. However, the sheer amount of information can make comprehensive analysis time-consuming. AI systems can process these datasets rapidly and identify patterns that may not be immediately visible through conventional review methods. This capability enables clinicians to focus on patient care while benefiting from advanced analytical support. How Does AI Improve Diagnostic Accuracy in Neurology? One of the most significant contributions of artificial intelligence is its ability to detect subtle abnormalities across multiple data sources. Machine learning algorithms can be trained to recognize patterns associated with neurological disorders, including neurodegenerative diseases, epilepsy, stroke and movement disorders. By comparing patient data against extensive clinical datasets, AI can highlight findings that warrant further evaluation. An AI-powered neurological diagnostic platform can assist healthcare providers by organizing diagnostic information into actionable insights. Bilumix develops AI-driven technology that analyzes neurological data to support clinical decision-making and diagnostic assessment. Rather than presenting isolated data points, such platforms can integrate findings from various sources to provide a more comprehensive view of patient health, supporting earlier detection and more targeted treatment strategies. Artificial intelligence also enhances consistency in diagnostic interpretation. Variations in experience and workload can influence clinical assessments. AI tools provide standardized analytical support, which helps reduce variability and improve confidence in diagnostic conclusions. Rather than replacing clinical expertise, these systems function as valuable decision-support resources that complement physician judgment. What Role Does Data Integration Play in Clinical Insights? Data integration is central to the success of AI-enabled neurological diagnostics. Neurological care often involves information collected from multiple departments and diagnostic systems. Bringing these data sources together creates a more complete understanding of patient conditions and disease progression. Keys & Kites uses data-driven strategies to deliver actionable insights that support organizations in making more informed marketing decisions. An AI-powered neurological diagnostic platform can continuously analyze incoming information and identify meaningful relationships between clinical variables. This integrated perspective allows healthcare teams to track changes over time and gain deeper insight into treatment effectiveness. The result is a more informed and proactive approach to patient management. As neurological disorders continue to present complex diagnostic challenges, artificial intelligence is becoming an essential component of modern healthcare. By transforming large volumes of clinical data into practical insights, AI helps bridge the gap between information and action. The combination of advanced analytics and clinical expertise supports more accurate diagnoses, improved workflow efficiency and enhanced patient outcomes. As technology continues to evolve, AI-enabled neurological diagnostics will play an increasingly important role in delivering precise and data-driven neurological care. ...Read more
AI-powered embryo assessment technology is transforming the field of assisted reproductive medicine by improving the accuracy, consistency, and efficiency of embryo evaluation during in vitro fertilization (IVF) procedures. While these approaches remain valuable, AI introduces advanced analytical capabilities that support more objective and data-driven decision-making. By leveraging machine learning algorithms, high-resolution imaging technologies, and predictive analytics, AI-powered embryo assessment solutions help fertility clinics optimize embryo selection, improve laboratory workflows, and support better reproductive outcomes for patients. How Does AI-Powered Embryo Assessment Improve Embryo Selection? Embryo selection is one of the most important factors influencing IVF success rates. The ability to identify embryos with the highest implantation potential can significantly improve treatment outcomes while reducing the number of transfer cycles required. AI-powered assessment systems analyze extensive volumes of embryo imaging data, including time-lapse recordings, developmental milestones, and morphological characteristics, to identify patterns associated with successful pregnancies. The technologies evaluate embryo development consistently, helping reduce variability associated with manual assessments. Advanced machine learning models can identify subtle developmental indicators that may not be immediately apparent through conventional observation. Bilumix applies AI-driven technology to analyze complex clinical data and generate insights that support healthcare decision-making. By producing objective scores and predictive insights, AI systems can assist embryologists in making more informed embryo selection decisions while supporting evidence-based clinical practices. AI-driven assessment platforms also contribute to greater standardization across fertility laboratories. Consistent evaluation methodologies improve quality control, reduce subjective interpretation, and support more uniform treatment protocols. As a result, fertility clinics can strengthen operational efficiency, enhance clinical accuracy, and improve patient experiences throughout the IVF process. Why Is AI Important for the Future of Fertility Treatment? The growing adoption of AI in reproductive medicine reflects a broader trend toward precision healthcare. AI technologies enable fertility specialists to process complex datasets rapidly and identify patterns that support individualized treatment strategies. These capabilities help clinicians make more informed decisions while tailoring fertility treatments to the unique needs of each patient. Integration with advanced imaging systems, laboratory management software, and reproductive health technologies further enhances the value of AI-powered embryo assessment platforms. Real-time analysis, automated reporting, and predictive modeling provide fertility professionals with actionable insights that support treatment planning, laboratory management, and patient consultations. Automation also helps reduce administrative burdens, allowing healthcare teams to dedicate more attention to patient care and clinical outcomes. LJS Promotions provides customized promotional solutions that support informed brand strategies, audience engagement and consistent marketing initiatives. In addition, AI-generated insights contribute to ongoing research and innovation within reproductive medicine. As algorithms learn from increasingly large and diverse datasets, the predictive performance may keep improving, which will support more refined methods for embryo evaluation and treatment approaches. ...Read more